25 June 2018 | News
The company is seeking approval to use the drug to treat Lennox-Gastaut and Dravet syndromes, which cause uncontrolled daily seizures and put patients at high risk for other physical and intellectual disabilities, injury and early death.
Singapore - A drug to treat childhood epilepsy is expected this week to become the first medicine derived from cannabis to be approved for sale in the U.S.
GW Pharmaceuticals has raised $1B from American healthcare funds during the past five years to develop Epidiolex.
FDA clearance would pave the way for the drug to be launched nationwide by the fall.